117 related articles for article (PubMed ID: 32262308)
1. The design and synthesis of a soluble composite silica xerogel and the short-time release of proteins.
Chen R; Qu H; Guo S; Ducheyne P
J Mater Chem B; 2015 Apr; 3(16):3141-3149. PubMed ID: 32262308
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of small molecules from silica xerogel with limited nanoporosity.
Chen R; Qu H; Agrawal A; Guo S; Ducheyne P
J Mater Sci Mater Med; 2013 Jan; 24(1):137-46. PubMed ID: 23053812
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of silica xerogels as carriers for drugs.
Czarnobaj K
Drug Deliv; 2008 Nov; 15(8):485-92. PubMed ID: 18798086
[TBL] [Abstract][Full Text] [Related]
4. In vitro bioactivity and degradation behavior of silica xerogels intended as controlled release materials.
Radin S; Falaize S; Lee MH; Ducheyne P
Biomaterials; 2002 Aug; 23(15):3113-22. PubMed ID: 12102182
[TBL] [Abstract][Full Text] [Related]
5. Correlation between physicochemical properties of doxorubicin-loaded silica/polydimethylsiloxane xerogel and in vitro release of drug.
Prokopowicz M
Acta Biomater; 2009 Jan; 5(1):193-207. PubMed ID: 18755642
[TBL] [Abstract][Full Text] [Related]
6. The effect of Na(2)CO(3), NaF and NH(4)OH on the stability and release behavior of sol-gel derived silica xerogels embedded with bioactive compounds.
Morpurgo M; Teoli D; Pignatto M; Attrezzi M; Spadaro F; Realdon N
Acta Biomater; 2010 Jun; 6(6):2246-53. PubMed ID: 20035908
[TBL] [Abstract][Full Text] [Related]
7. Influence of surfactants on the release behaviour and structural properties of sol-gel derived silica xerogels embedded with metronidazole.
Czarnobaj K; Sawicki W
Pharm Dev Technol; 2013; 18(2):377-83. PubMed ID: 22107265
[TBL] [Abstract][Full Text] [Related]
8. Sol-gel processed porous silica carriers for the controlled release of diclofenac diethylamine.
Czarnobaj K; Czarnobaj J
J Biomed Mater Res B Appl Biomater; 2008 Oct; 87(1):114-20. PubMed ID: 18437709
[TBL] [Abstract][Full Text] [Related]
9. In vitro release of cisplatin from sol-gel processed organically modified silica xerogels.
Czarnobaj K; Lukasiak J
J Mater Sci Mater Med; 2007 Oct; 18(10):2041-4. PubMed ID: 17558477
[TBL] [Abstract][Full Text] [Related]
10. In vitro release behavior of toremifene citrate from sol-gel processed sintered silica xerogels.
Ahola M; Kortesuo P; Kangasniemi I; Kiesvaara J; Yli-Urpo A
Drug Dev Ind Pharm; 1999 Aug; 25(8):955-9. PubMed ID: 10434140
[TBL] [Abstract][Full Text] [Related]
11. In-vitro controlled release of doxorubicin from silica xerogels.
Prokopowicz M
J Pharm Pharmacol; 2007 Oct; 59(10):1365-73. PubMed ID: 17910811
[TBL] [Abstract][Full Text] [Related]
12. Silica sol-gel for the controlled release of antibiotics. II. The effect of synthesis parameters on the in vitro release kinetics of vanomycin.
Aughenbaugh W; Radin S; Ducheyne P
J Biomed Mater Res; 2001 Dec; 57(3):321-6. PubMed ID: 11584809
[TBL] [Abstract][Full Text] [Related]
13. The Role of Polydimethylsiloxane in the Molecular Structure of Silica Xerogels Intended for Drug Carriers.
Czarnobaj K
Sci Pharm; 2015; 83(3):519-34. PubMed ID: 26839836
[TBL] [Abstract][Full Text] [Related]
14. Silica xerogels as a delivery system for the controlled release of different molecular weight heparins.
Roveri N; Morpurgo M; Palazzo B; Parma B; Vivi L
Anal Bioanal Chem; 2005 Feb; 381(3):601-6. PubMed ID: 15289979
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of Coloration in Photochromic Tungsten(VI) Oxide/Silicon Oxycarbide/Silica Hybrid Xerogel: Insight into Cation Self-diffusion Mechanisms.
Adachi K; Tokushige M; Omata K; Yamazaki S; Iwadate Y
ACS Appl Mater Interfaces; 2016 Jun; 8(22):14019-28. PubMed ID: 27159661
[TBL] [Abstract][Full Text] [Related]
16. Drug Release as a function of bioactivity, incubation regime, liquid, and initial load: Release of bortezomib from calcium phosphate-containing silica/collagen xerogels.
Kruppke B; Hose D; Schnettler R; Seckinger A; Rößler S; Hanke T; Heinemann S
J Biomed Mater Res B Appl Biomater; 2018 Apr; 106(3):1165-1173. PubMed ID: 28556562
[TBL] [Abstract][Full Text] [Related]
17. Tunability of Hybrid Silica Xerogels: Surface Chemistry and Porous Texture Based on the Aromatic Precursor.
Rosales-Reina B; Cruz-Quesada G; Padilla-Postigo N; Irigoyen-Razquin M; Alonso-Martínez E; López-Ramón MV; Espinal-Viguri M; Garrido JJ
Gels; 2023 May; 9(5):. PubMed ID: 37232974
[TBL] [Abstract][Full Text] [Related]
18. Controlled release of lidocaine hydrochloride from the surfactant-doped hybrid xerogels.
Wu Z; Joo H; Lee TG; Lee K
J Control Release; 2005 Jun; 104(3):497-505. PubMed ID: 15911049
[TBL] [Abstract][Full Text] [Related]
19. Silica xerogels as pharmaceutical drug carriers.
Quintanar-Guerrero D; Ganem-Quintanar A; Nava-Arzaluz MG; Piñón-Segundo E
Expert Opin Drug Deliv; 2009 May; 6(5):485-98. PubMed ID: 19413456
[TBL] [Abstract][Full Text] [Related]
20. Chlorophyll a Covalently Bonded to Organo-Modified Translucent Silica Xerogels: Optimizing Fluorescence and Maximum Loading.
García-Sánchez MA; Serratos IN; Sosa R; Tapia-Esquivel T; González-García F; Rojas-González F; Tello-Solís SR; Palacios-Enriquez AY; Esparza Schulz JM; Arrieta A
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
